Sun Pharma Leqselvi US launch, Leqselvi alopecia areata, Leqselvi deuruxolitinib

Sun Pharma Launches Leqselvi in U.S. After Patent Settlement—New Alopecia Areata Treatment Targets $900M Market

A major update is here—Sun Pharmaceutical Industries, one of India’s largest drugmakers, has officially launched its much-awaited hair loss treatment Leqselvi™ (deuruxolitinib) 8 mg tablets in the U.S. This launch comes after the settlement of a patent infringement case with Delaware-based Incyte Corporation. Sun Pharma Leqselvi US launch is expected to make waves in the […]